Ovine Brucellosis: Diagnosis and Management

By Dr. Zubair Khalid, DVM, MS, PhD · 2026-08-11

Key Takeaways

• Ovine brucellosis is caused by Brucella ovis, a rough LPS strain with negligible zoonotic potential, primarily manifesting as ram epididymitis and reduced flock reproductive efficiency.
• Transmission is predominantly venereal, with infected rams shedding B. ovis in semen, but ram-to-ram contact and contaminated environments also contribute to spread.
• Diagnostic strategies rely heavily on serology (ELISA, CFT, RBT) with confirmatory PCR on semen or tissues, but serological cross-reactivity with enteric bacteria like Yersinia enterocolitica O:9 is a significant pitfall.
• Control pillars include a rigorous test-and-cull program, strict biosecurity protocols for introduced animals, and in endemic regions, vaccination with B. melitensis Rev.1, which however complicates serological interpretation.
• Clinical presentation in rams is typically unilateral, fibrotic epididymitis, while ewes often exhibit subclinical infection or milder signs like weak lambs and retained placentas, making early detection challenging.
• Management failures often stem from incomplete detection of subclinical or chronically infected animals, reintroduction of infection, or misinterpretation of vaccine-induced antibody responses.

Ovine brucellosis is a contagious reproductive disease of sheep caused by Brucella ovis, a rough lipopolysaccharide (LPS) strain of Brucella that is host-adapted to sheep. Unlike the smooth strains B. melitensis and B. abortus, B. ovis is not considered a significant zoonotic threat, but it remains a major cause of ram epididymitis and flock reproductive inefficiency worldwide. This article provides a diagnostic-reasoning framework for the practicing veterinarian, covering the pathogenesis, clinical presentation, laboratory testing strategies, and evidence-based control measures for B. ovis infection in commercial and stud flocks.

The clinical question this reference addresses is direct: when a ram presents with scrotal enlargement, a ewe aborts, or a flock experiences poor lambing percentages, how does the clinician distinguish B. ovis from other causes of ovine reproductive failure, and what management response is appropriate? The article also covers the distinction between B. ovis and the smooth brucellae, because the serological cross-reactions and regulatory implications differ substantially. Vaccination options, biosecurity protocols, and the interpretation of test results in vaccinated versus infected flocks are discussed with attention to the limitations of the current evidence base.

At a Glance

Etiology and Strain Characteriztics

Brucella ovis belongs to the genus Brucella, a group of facultative intracellular Gram-negative coccobacilli. The species is distinguished by its rough LPS phenotype, which lacks the O-polysaccharide side chains present on smooth strains such as B. melitensis and B. abortus. This structural difference has two practical consequences. First, it explains why B. ovis is largely non-pathogenic for humans, since the smooth LPS is a major virulence factor for human disease. Second, it determines the serological tests that are useful for diagnosis, because tests based on smooth LPS antigens will not reliably detect B. ovis infection.

The organizm is fastidious and slow-growing in culture, requiring enriched media and increased carbon dioxide tension for primary isolation. These culture requirements, combined with intermittent shedding, make bacteriology an insensitive diagnostic approach in live animals. The pathogenesis of B. ovis infection has been studied in a pregnant mouse model, where wild-type infection produces necrotizing placentitis and microgranulomas in the liver and spleen, lesions that parallel those seen with B. abortus in the same model. This experimental evidence supports the view that B. ovis is a genuine abortifacient pathogen, also a colonizer of the genital tract.

Epidemiology and Transmission

Brucella ovis is distributed worldwide and is particularly prevalent in regions with intensive sheep production. Seroprevalence studies from endemic areas illustrate the scale of the problem. A cross-sectional survey in Egypt's Kafrelsheikh district, using Rose Bengal plate testing with complement fixation confirmation, estimated true animal-level seroprevalence at 20 percent, with 95.5 percent of villages having at least one seropositive sheep. A separate study in central-eastern Tunisia, using serology and IS711-based real-time PCR, reported a true adjusted animal-level prevalence of 13.5 percent in sheep and a herd-level prevalence of 21.8 percent. These figures underscore that B. ovis is a common cause of reproductive loss in many production systems, and that herd-level exposure is often far higher than individual animal prevalence suggests.

Transmission occurs primarily through venereal contact. Infected rams shed the organizm in semen, often for months or years, and the organizm can persist in the epididymis and accessory sex glands. Ewes can also transmit infection to rams during breeding, and ram-to-ram transmission occurs through homosexual mounting behavior, which is common in ram groups. Contaminated bedding and equipment serve as minor but non-negligible sources of spread. The organizm does not survive long in the environment, so indirect transmission requires recent contamination.

Clinical Presentation

Ram Disease

Epididymitis is the hallmark of B. ovis infection in rams. The lesion is typically unilateral and begins as an acute inflammatory swelling of the epididymis, often the tail, which may be painful and warm on palpation. The acute phase may be accompanied by fever and reduced libido, but these signs are often missed in flock settings. Over weeks, the swelling becomes fibrotic and the affected epididymis becomes firm, nodular, and non-painful. The testicle itself may atrophy secondary to increased intratubular pressure and impaired thermoregulation. Semen quality deteriorates, with reduced sperm motility, increased morphological abnormalities, and the presence of inflammatory cells and detached sperm heads.

Not all infected rams develop palpable lesions. Subclinical infection is common, and such rams can shed B. ovis in semen while appearing normal on breeding soundness examination. This is a critical diagnostic trap, because visual and palpatory examination alone will miss a substantial proportion of infected animals. The Society for Theriogenology provides resources on breeding soundness evaluation that emphasize the need for semen collection and laboratory assessment in addition to physical examination.

Ewe Disease

Ewes infected with B. ovis typically show milder signs than rams. Abortion in the last trimester, stillbirth, and the birth of weak lambs are reported, but many infected ewes carry lambs to term and show no obvious clinical abnormality. The organizm localizes in the placenta and fetal fluids, and infected ewes may shed the organizm in vaginal discharge for several weeks after lambing. Retained placenta and metritis occur in a minority of cases. The economic impact in ewes is therefore often underestimated, manifesting as reduced lamb survival and increased barren rates instead of dramatic abortion storms.

Diagnostic Approach

Serology

Serological testing is the mainstay of B. ovis diagnosis in live animals. The complement fixation test (CFT) has historically been the reference method, and it remains useful for confirmation. Enzyme-linked immunosorbent assays (ELISAs) are now widely used for screening because they are more sensitive, less labor-intensive, and not subject to the prozone phenomena that can complicate CFT interpretation. The Rose Bengal test (RBT), which is a standard screening tool for smooth brucellosis, is also used in some B. ovis testing protocols, but its performance for rough strains requires careful validation.

A major diagnostic challenge is serological cross-reactivity. Antibodies induced by Yersinia enterocolitica O:9 and Escherichia coli O157:H7 can produce false-positive reactions in brucellosis serology, as demonstrated in experimental infection studies in sheep. These cross-reactions are particularly problematic in the final stages of eradication programs and in surveillance of brucellosis-free areas, where the positive predictive value of any test declines as true prevalence falls. The World Organization for Animal Health (WOAH) publishes terrestrial animal health standards that address test validation and interpretation, and the clinician should consult these standards when designing a flock testing protocol.

Bacteriology and Molecular Methods

Culture of B. ovis from semen, epididymal tissue, or vaginal swabs provides definitive diagnosis, but sensitivity is limited by intermittent shedding and the organizm's fastidious growth requirements. PCR-based methods, including IS711-targeted real-time PCR, offer improved sensitivity and faster turnaround, and they have been used successfully in large-scale prevalence studies. PCR is particularly valuable for confirming infection in seropositive animals before culling decisions are made, and for detecting the organizm in aborted fetal tissues.

Flock-Level Testing Strategy

The diagnostic sequence for ovine brucellosis depends on the purpose of testing. A pre-purchase examination of a ram requires a different protocol than a whole-flock eradication program. Define the objective before selecting tests, because the predictive value of each assay shifts with disease prevalence.

For individual ram certification, begin with serology using a complement fixation test (CFT) or an indirect ELISA validated for Brucella ovis. Confirm any positive result with a second test of different principle, preferably bacteriology or PCR on semen or epididymal fluid. A single positive CFT titre in a ram with palpable epididymal lesions is sufficient to classify the animal as infected for management purposes.

For flock screening, test all rams older than six months. Sample ewes only when investigating abortion outbreaks or when the flock has a known history of infection. Testing lambs before weaning adds little diagnostic value because maternal antibody may persist for several months and peripubertal transmission has not yet occurred.

The WOAH terrestrial animal health standards describe the internationally accepted test methods and their interpretation for trade purposes. Where national programs exist, their requirements supersede general recommendations.

Interpretation of Serological Results

CFT remains the reference method for B. ovis serology in many jurisdictions. The test detects IgG antibodies that fix complement, and it becomes positive later in infection than ELISA. A rising CFT titre on paired samples collected two to three weeks apart supports active infection.

Indirect ELISAs offer higher sensitivity and are well suited to automated laboratory workflows. Their principal limitation is false-positive reactions caused by cross-reacting antibodies. Experimental work has shown that Yersinia enterocolitica O:9 and Escherichia coli O157:H7 can induce antibodies that interfere with brucellosis serology, and this cross-reactivity complicates interpretation in flocks with concurrent enteric infections cross-reactivity in serological tests for brucellosis. When an ELISA result is positive but the CFT is negative, repeat both tests after three weeks before making a culling decision.

Sampling Technique for Bacteriology and PCR

Collect semen by electroejaculation into a sterile container. Process the sample within 24 hours if it is to be cultured, or store frozen at minus 20 degrees Celsius for PCR. Epididymal fluid collected at necropsy is a suitable alternative when semen collection is not feasible.

For PCR, swab the vaginal fornix of ewes that have aborted within the preceding 48 hours. Placental cotyledons and fetal abomasal contents are also suitable specimens. The IS711-based real-time PCR assay detects Brucella genus DNA and does not distinguish B. ovis from other species, so positive results should be followed by species-specific testing where the distinction matters a mixed methods study of ruminant brucellosis in central-eastern Tunisia.

Differential Diagnosis of Ram Epididymitis

Epididymitis in rams has several infectious causes that produce similar clinical findings. B. ovis is the most common bacterial cause in many regions, but Actinobacillus seminis, Histophilus somni, and Corynebacterium pseudotuberculosis can also cause epididymal lesions. The Society for Theriogenology resources provide additional guidance on breeding soundness evaluation and the interpretation of genital tract findings.

Palpation alone cannot distinguish these causes. A ram with a firm, enlarged epididymis and normal testicular tone may have B. ovis infection, but the same findings occur with actinobacillosis. Semen quality deteriorates with all of these infections, so poor motility and abnormal morphology do not narrow the diagnosis.

The distinction matters for flock management. B. ovis infection is persistent and the ram remains a shedding risk for life. A. seminis infection may be transient, and some affected rams recover fertility after treatment. Culture or PCR on semen is the only reliable way to differentiate these conditions.

The Diagnostic Testing Algorithm

Apply the following sequence when ovine brucellosis is suspected in a flock:

1. Define the testing objective: pre-purchase certification, abortion investigation, or eradication program monitoring.
2. Screen all rams with an indirect ELISA or CFT. In an abortion outbreak, also test the ewes that aborted.
3. Confirm all positive serological results with a second test of different principle. PCR on semen is preferred for rams, PCR on vaginal swabs or placental tissue is preferred for ewes.
4. Isolate and cull confirmed positive animals. Repeat testing of the remaining flock after 60 days.
5. Where the flock has a history of infection, repeat the entire screening cycle at least twice at 60-day intervals before declaring the flock free of infection.

The algorithm changes when testing is performed in a region with a known high prevalence of cross-reacting enteric infections. In that setting, confirm every serological positive with PCR instead of a second serological test, because the second serological test may also be affected by the same cross-reacting antibodies cross-reactivity in serological tests for brucellosis.

Flock Control and Eradication

Test-and-Cull Strategy

Test-and-cull is the preferred approach in flocks with a low prevalence of infection and where the owner is willing to remove positive animals. The strategy requires rigorous biosecurity to prevent reintroduction. All incoming rams must test negative on two occasions 60 days apart before entering the flock. Replacements should come from certified free flocks where possible.

The main failure mode of test-and-cull is incomplete detection. Chronically infected rams may have CFT titres that fall below the positive threshold, particularly in the later stages of infection. PCR on semen detects these animals more reliably, but the cost per animal is higher. In a high-value stud flock, the additional expense is justified.

Vaccination

Vaccination with Brucella melitensis Rev.1 is the principal control measure in regions where ovine brucellosis is endemic and test-and-cull is not economically feasible. The vaccine is a live attenuated strain that protects against both B. melitensis and B. ovis infection evaluation of brucellosis vaccines. Rev.1 produces persistent serological responses that interfere with diagnostic testing, which complicates its use in flocks that also participate in surveillance programs.

The vaccine is administered to lambs between three and six months of age, before the onset of sexual maturity. Vaccinating adult rams is not recommended because the vaccine can cause epididymitis and orchitis. The MSD Veterinary Manual provides further detail on vaccine handling and administration protocols.

Rev.1 is a live vaccine and poses a human health risk. Vaccinators should wear protective clothing and avoid self-inoculation. The vaccine strain is susceptible to standard disinfectants, but contaminated equipment should be handled with care.

Acellular vaccine candidates are under investigation as safer alternatives to Rev.1. These vaccines aim to provide protection without the serological interference and safety concerns of live vaccines acellular vaccines for ovine brucellosis. None of these candidates is commercially available at the time of writing, and their field efficacy remains to be established.

Biosecurity and Herd Management

Biosecurity measures reduce the risk of introducing B. ovis into a clean flock. Maintain a closed flock wherever possible. Where introductions are necessary, purchase only from flocks with a documented negative testing history. Quarantine new animals for at least 60 days and test them twice during the quarantine period.

Separate rams from ewes outside the breeding season. This reduces the opportunity for venereal transmission and makes the flock easier to manage if an outbreak occurs. During lambing, remove aborted fetuses and placentas promptly and dispose of them by incineration or deep burial. The practice of throwing aborted material into water canals, documented in some endemic regions, perpetuates environmental contamination and should be actively discouraged seroprevalence and knowledge, attitudes and practices survey of endemic ovine brucellosis in Egypt.

Monitoring and Documentation

Record all testing results, including the test method, laboratory, date, and the identification of each animal. Maintain a flock health calendar that schedules routine testing at intervals appropriate to the local disease status. In a free flock, annual testing of all rams is a reasonable minimum. In a flock recovering from an outbreak, test every 60 days until two consecutive negative whole-flock tests are achieved.

Document the disposal method for culled animals and the cleaning and disinfection of facilities that housed positive animals. These records support the flock's health status claims and are essential if the owner seeks certification for trade purposes under WOAH terrestrial animal health standards.

Recognized Complications and Failure Modes

The most consequential failure in ovine brucellosis management is the persistence of infection within a flock despite an apparent test-and-cull program. This occurs when infected rams are tested during the prepatent period, when seroconversion has not yet occurred, or when chronically infected rams have antibody titres that fall below the diagnostic threshold of the screening test. Detection of this failure mode requires repeat testing at intervals of at least four to six weeks, with a minimum of two consecutive negative flock tests before freedom from infection can be considered.

A second failure mode is the introduction of infection through a purchased ram that has passed a single pre-sale serological test. The sensitivity of a single serological test in an individual animal is imperfect, and the incubation period can exceed the interval between testing and sale. Quarantine of introduced rams for 60 to 90 days with repeat serological testing before commingling is the corrective measure.

Vaccination with live attenuated Brucella melitensis Rev.1 in a flock that is already infected can complicate interpretation of subsequent serological testing, as persistent antibody responses are a recognized limitation of this vaccine evaluation of brucellosis vaccines. This is particularly problematic in ram lambs vaccinated after the recommended age window or in ewes vaccinated during pregnancy, where both safety and diagnostic interference are amplified. The corrective action is to vaccinate only replacement animals within the labelled age range and to use a testing strategy that distinguishes vaccine-induced antibody from field infection, where such differentiation is available.

Common Diagnostic Errors

Less experienced clinicians frequently attribute ram epididymitis to non-infectious causes without performing bacteriological culture. While semen evaluation and palpation identify the lesion, they do not establish the aetiology. The corrective action is to submit semen or epididymal aspirate for culture whenever Brucella ovis is within the differential diagnosis, particularly in flocks with a history of abortion or reduced lambing percentage.

A second common error is the over-interpretation of a single positive serological result in a ewe that has aborted. Cross-reactions with Yersinia enterocolitica O:9 and Escherichia coli O157:H7 can produce false-positive serological reactions in brucellosis testing, and these cross-reactions are a recognized limitation of the standard serological methods cross-reactivity in serological tests for brucellosis. The corrective action is to confirm positive screening results with a second test of different principle, such as complement fixation or an ELISA, and to interpret results in the context of flock-level prevalence and clinical history.

A third error is the failure to collect appropriate samples from aborted fetuses. Autolysis, contamination, and delayed submission reduce the diagnostic yield of culture and PCR substantially. The corrective action is to collect fetal abomasal contents, lung, liver, and cotyledon promptly, refrigerate instead of freeze samples destined for culture, and transport them to the laboratory without delay.

Troubleshooting Table

Limitations of the Evidence and Areas of Expert Disagreement

The evidence base for Brucella ovis control is less developed than that for Brucella melitensis. Much of the published literature addresses B. melitensis, and extrapolation to B. ovis is not always valid. The pathogenesis of B. ovis infection has been studied in mouse models, which demonstrate transplacental infection and necrotising placentitis similar to that caused by B. abortus, but the relevance of these findings to natural ovine infection is uncertain pathogenesis of Brucella ovis in pregnant mice.

Expert opinion differs on the role of vaccination in flocks with endemic infection. Some authorities recommend whole-flock vaccination with Rev.1 as a means of reducing shedding and abortion, while others restrict vaccination to replacement animals to preserve the diagnostic value of serological testing. The safety drawbacks of Rev.1, including abortion in pregnant ewes and persistent serological responses, have driven interest in acellular vaccine candidates, but none is commercially available acellular vaccines for ovine brucellosis.

The true prevalence of B. ovis infection is difficult to establish because many infected flocks are subclinical and because serological surveys vary in test performance and sampling strategy. Studies from endemic regions report substantial flock-level prevalence, but these figures cannot be generalized to other production systems seroprevalence of endemic ovine brucellosis in Egypt.

Referral, Consultation, and Regulatory Reporting

Referral to a veterinary reproduction specialist is warranted when a ram with epididymitis is of high genetic value and salvage of breeding soundness is contemplated, when a flock has failed to clear infection after two complete test-and-cull cycles, or when the clinician is uncertain about the interpretation of discordant serological results. The Society for Theriogenology maintains resources on breeding soundness evaluation and reproductive health management that can support such consultations Society for Theriogenology resources.

Laboratory involvement is required for bacteriological culture, PCR, and confirmatory serology. The clinician should contact the laboratory before sample submission to confirm specimen requirements, transport conditions, and expected turnaround times.

Regulatory reporting obligations vary by jurisdiction. Brucella ovis is notifiable in some regions but not others, and the distinction between B. ovis and B. melitensis is critical because the latter has greater zoonotic significance. Clinicians should consult their regional veterinary authority and the World Organization for Animal Health terrestrial standards to determine local requirements WOAH terrestrial animal health standards. Where B. melitensis is suspected, reporting is mandatory in most countries, and samples should be handled under appropriate containment conditions.

Frequently Asked Questions

How should I prioritize testing when laboratory access or budget is limited?

When resources are constrained, begin with the Rose Bengal test as a flock-level screening tool because it is inexpensive and rapid. Confirm all positive results with complement fixation testing or an ELISA before culling decisions, as false positives occur with cross-reacting bacteria such as Yersinia enterocolitica O:9 and Escherichia coli O157:H7, as described in serological cross-reactivity studies. Test rams first, since they are the primary maintenance host. If you can sample only a subset of ewes, prioritize those that have aborted or lambed weakly. Pooled sampling is not validated for Brucella ovis serology, so individual samples remain necessary. Where confirmatory testing is unavailable, interpret positive Rose Bengal results cautiously and repeat testing after four to six weeks before recommending culling.

What should I do when the flock has no handling facilities suitable for safe blood collection?

Manual restraint with a well-designed tilt table or a purpose-built race is the safest option, but many small flocks lack these. A shepherd experienced in holding sheep can allow jugular venepuncture with the animal seated on its rump, provided two people are present. Avoid chasing sheep repeatedly, as stress and hyperthermia affect sample quality. Use the smallest practical needle gauge and collect into plain tubes for serology. If venepuncture is truly impossible, consider using the owner's veterinary practitioner for sampling visits, or arrange a central collection point where several flocks bring animals. Document any deviation from standard sampling protocols in the herd record, since sample quality affects interpretation of international surveillance standards.

How does the approach differ in a mixed flock containing both sheep and goats?

Brucella melitensis is the primary concern in goats and can infect sheep, whereas Brucella ovis is essentially ovine-specific. In mixed flocks, serological testing must distinguish between these agents because the clinical and regulatory consequences differ substantially. The Rose Bengal test and complement fixation test detect smooth Brucella species and will not reliably identify B. ovis infection, as noted in reviews of ovine brucellosis vaccines and diagnosis. Use species-specific antigens or PCR to differentiate. Control programs in mixed flocks should target the more pathogenic species present. Consult professional veterinary resources for guidance on species-specific testing protocols, and be aware that regulatory reporting requirements may differ between sheep and goats in your jurisdiction.

What records should I maintain during a control program?

Maintain an individual animal register with permanent identification, age, sex, breeding history, and all test results with dates and laboratory accession numbers. Record vaccination status separately from natural infection, since vaccine-induced antibodies complicate interpretation. Document abortion events, lambing outcomes, and ram breeding assignments. Keep a flock-level log of biosecurity practices, including introductions, isolation periods, and shared grazing arrangements. These records support traceability during eradication and provide evidence of compliance with terrestrial animal health standards. Review the register at each testing round to identify untested animals, which are a common cause of apparent treatment failure. Digital spreadsheets are adequate for small flocks, but larger operations benefit from dedicated flock health software.

How do I explain test results and culling recommendations to a producer who is reluctant to cull?

Frame the discussion around flock-level risk instead of individual animal value. Explain that a single infected ram can infect multiple ewes during a breeding season, and that retained seropositive animals perpetuate transmission. Use the flock's own testing data to show the trajectory of prevalence over time. Acknowledge the economic hardship of culling and discuss whether vaccination is appropriate in their context, noting that live attenuated vaccines such as Rev.1 are effective but cause persistent serological responses that complicate future testing. Offer a written plan with clear timelines and expected outcomes. If the producer refuses culling, document this decision and recommend strict segregation of positive animals, separate breeding groups, and enhanced biosecurity as a partial mitigation.

When should I refer a case or seek specialist input?

Refer when you encounter diagnostic uncertainty, particularly when serological results are discordant between tests or when clinical signs suggest B. melitensis instead of B. ovis. Seek specialist advice before initiating a flock eradication program in a high-prevalence flock, since the economic and logistical demands are substantial. Contact your regulatory veterinary authority early, as ovine brucellosis may be notifiable in your region and control programs often require official oversight. The Society for Theriogenology offers resources on ram breeding soundness evaluation and reproductive flock health that may support your investigation. Refer also when human exposure has occurred, particularly after assisted lambing or abortion handling, so that occupational health follow-up can be arranged.

Related Clinical & Scientific Guides

• Diagnostic Approach to Canine Infertility in the Bitch
• Canine Neonatal Resuscitation: Protocol and Monitoring
• Equine Breeding Soundness Examination of the Stallion

References and Further Reading

• Evaluation of Brucellosis Vaccines: A Comprehensive Review.. 2022.
• Acellular vaccines for ovine brucellosis: a safer alternative against a worldwide disease.. 2012.
• Cross-reactivity in serological tests for brucellosis: a comparison of immune response of Escherichia coli O157:H7 and Yersinia enterocolitica O:9 vs Brucella spp.. 2018.
• Seroprevalence and "Knowledge, Attitudes and Practices" (KAPs) survey of endemic ovine brucellosis in Egypt.. 2016.
• A mixed methods study of ruminant brucellosis in central-eastern Tunisia.. 2017.
• Pathogenesis of Brucella ovis in pregnant mice and protection induced by the candidate vaccine strain B. Ovis ΔabcBA.. 2022.
• Society for Theriogenology Resources. Society for Theriogenology.
• MSD Veterinary Manual, Professional Edition. MSD Veterinary Manual.
• American Veterinary Medical Association Practice Resources. American Veterinary Medical Association.

Related Articles

• Caprine Brucellosis: Diagnosis and Management
• Equine Brucellosis: Diagnosis and Management
• Ovine Pregnancy Diagnosis: Transabdominal Ultrasound and Management
• Feline Dystocia: Diagnosis and Management
• Dystocia in Mares: Diagnosis and Management

This article is educational professional reference material for veterinary audiences. It is not a substitute for veterinary diagnosis, individual clinical judgment, current product labeling, or applicable regulatory requirements.